Are GLP-1’s Going To Be A Frontline Treatment For PCOS?
Do GLP-1 Analogs Have a Place in the Treatment of PCOS?
(Journal of Clinical Medicine, PMC)
This review explores how GLP-1 receptor agonists—like semaglutide (Ozempic)—may offer promising metabolic and reproductive benefits for women with polycystic ovary syndrome (PCOS). It highlights their impact on weight loss, insulin regulation, and lipid profiles, underscoring their potential role in managing PCOS symptoms. However, the paper advises careful patient screening and ongoing monitoring due to possible contraindications.
Read the full study here
Jean (PCOS Editor)
I’m Jean, a seasoned editor with 10 years of experience in digital health content, specializing in GLP-1 therapies and PCOS. I create clear, compelling online articles and posts that simplify complex health topics while maintaining accuracy. With a background in health communications, I prioritize engagement and clarity. In my free time, I dive into the latest wellness trends.